Previous Article | Next Article 
Molecular and Cellular Biology, April 2001, p. 2521-2532, Vol. 21, No. 7
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.7.2521-2532.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Essential Role of Insulin Receptor Substrate 1 (IRS-1) and IRS-2 in Adipocyte Differentiation
Hiroshi
Miki,1
Toshimasa
Yamauchi,1
Ryo
Suzuki,1
Kajuro
Komeda,2
Atsuko
Tsuchida,2
Naoto
Kubota,1
Yasuo
Terauchi,1
Junji
Kamon,1
Yasushi
Kaburagi,1
Junji
Matsui,1
Yasuo
Akanuma,3
Ryozo
Nagai,1
Satoshi
Kimura,1
Kazuyuki
Tobe,1 and
Takashi
Kadowaki1,*
Department of Internal Medicine, Graduate
School of Medicine, University of Tokyo, Tokyo
113-8655,1 Division of Laboratory Animal
Science, Animal Research Center, Tokyo Medical University, Tokyo
160-8402,2 and Institute for
Diabetes Care and Research, Asahi Life Foundation, Tokyo
100-0005,3 Japan
Received 10 July 2000/Returned for modification 30 August
2000/Accepted 20 December 2000
 |
ABSTRACT |
To investigate the role of insulin receptor substrate 1 (IRS-1) and
IRS-2, the two ubiquitously expressed IRS proteins, in adipocyte
differentiation, we established embryonic fibroblast cells with four
different genotypes, i.e., wild-type, IRS-1 deficient (IRS-1
/
), IRS-2 deficient (IRS-2
/
), and
IRS-1 IRS-2 double deficient (IRS-1
/
IRS-2
/
), from mouse embryos of the corresponding
genotypes. The abilities of IRS-1
/
cells and
IRS-2
/
cells to differentiate into adipocytes are
approximately 60 and 15%, respectively, lower than that of wild-type
cells, at day 8 after induction and, surprisingly,
IRS-1
/
IRS-2
/
cells have no ability to
differentiate into adipocytes. The expression of CCAAT/enhancer binding
protein
(C/EBP
) and peroxisome proliferator-activated receptor
(PPAR
) is severely decreased in IRS-1
/
IRS-2
/
cells at both the mRNA and the protein level,
and the mRNAs of lipoprotein lipase and adipocyte fatty acid binding
protein are severely decreased in IRS-1
/
IRS-2
/
cells. Phosphatidylinositol 3-kinase (PI
3-kinase) activity that increases during adipocyte differentiation is
almost completely abolished in IRS-1
/
IRS-2
/
cells. Treatment of wild-type cells with a PI
3-kinase inhibitor, LY294002, markedly decreases the expression of
C/EBP
and PPAR
, a result which is associated with a complete
block of adipocyte differentiation. Moreover, histologic analysis of
IRS-1
/
IRS-2
/
double-knockout mice
8 h after birth reveals severe reduction in white adipose tissue
mass. Our results suggest that IRS-1 and IRS-2 play a crucial role in
the upregulation of the C/EBP
and PPAR
expression and adipocyte differentiation.
 |
INTRODUCTION |
Recently there has been a dramatic
increase in the prevalence of obesity attributable to excessive white
adipose tissue both in Western countries and in Japan. Because
adipocytes play a critical role in energy balance, understanding the
molecular mechanisms of adipocyte differentiation may provide clues to
strategies for the prevention and treatment of obesity.
The mechanisms of adipocyte differentiation have been extensively
studied in preadipocyte culture systems. Characterization of the
regulatory regions of adipose-specific genes has led to the
identification of key transcription factors in the complex transcriptional cascade that occurs during adipocyte differentiation (36); these factors include peroxisome
proliferator-activated receptor
(PPAR
) (19, 44),
CCAAT/enhancer binding protein (C/EBP) (12, 23, 32, 46, 52,
56), and adipocyte differentiation and determination factor 1 (ADD1)-sterol regulatory element binding protein 1c (SREBP1c)
(17, 18, 36, 45).
PPAR
is induced before the transcriptional activation of most
adipocyte-specific genes, and expression of PPAR
has been shown to
be sufficient to induce growth arrest and to initiate adipogenesis in
exponentially growing fibroblast cell lines, thus demonstrating its
critical role in the regulation of adipocyte differentiation (2,
15, 43). In addition, PPAR
-deficient cells fail to
differentiate into adipocytes, indicating that PPAR
plays a pivotal
role in adipocyte differentiation (21, 29). Most of the
PPAR
target genes in adipose tissue including the genes encoding
phosphoenolpyruvate carboxykinase (41), lipoprotein lipase
(LPL) (33) and adipocyte fatty acid binding protein
(A-FABP or aP2) (42) are directly implicated in lipogenic pathways.
C/EBP
is the most highly expressed member of C/EBP family in adipose
tissue and in liver and has been implicated in the maintenance of the
terminally differentiated adipocyte phenotype (4, 9, 25,
56). C/EBP
is induced relatively late during adipogenesis in
culture, after the induction of PPAR
but before the induction of
many of the enzymes and proteins characteristic of fully differentiated cells (53), and it transcriptionally activates a large
number of adipocyte-specific genes (8). C/EBP
-null mice
fail to develop white adipose tissue (48), and
C/EBP
-deficient cells fail to differentiate into adipocytes
(51). C/EBP
(1, 7, 9, 10, 56) and C/EBP
(4, 16, 49) are induced very early and have been shown to
play a crucial role in initiating the differentiation of preadipocytes
by activating the expression of PPAR
(39, 50, 52, 56).
An in vitro study of adipocyte differentiation in
C/EBP
/
C/EBP
/
embryonic
fibroblast (EF) cells shows that the expression of both PPAR
and
C/EBP
is severely reduced (39).
In addition, there is a large amount of literature describing
extracellular factors that influence adipogenic potentials. These
include insulin-like growth factor 1 (IGF-1) and insulin. However,
little is known about the signal transduction pathways by which these
hormones regulate the expression of these transcription factors and
promote adipogenesis.
IRS-1 and IRS-2 are the two most ubiquitously expressed members of the
IRS family of proteins, which can bind signaling proteins with
Src-homology-2 domains (SH2 proteins), such as p85 regulatory subunit
of phosphatidylinositol 3-kinase (PI 3-kinase), subsequent to the
activation of receptors for insulin, IGF-1, and several cytokines
(26, 28, 37). IRS-1 plays an important role in the
metabolic actions of insulin and IGF-1 mainly in skeletal muscle and
adipose tissue, and IRS-2 plays an important role in the metabolic
actions of these hormones in the liver (3, 55). The roles
of IRS-1 and IRS-2 in adipocyte differentiation, on the other hand,
have not been reported.
To investigate the role of IRS-1 and IRS-2 in adipocyte
differentiation, we intercrossed mice heterozygous for each of two null
alleles (Irs1+/
[38] and
Irs2+/
[22]) and generated primary
EF cells that were wild type, IRS-1 deficient (IRS-1
/
),
IRS-2 deficient (IRS-2
/
), or IRS-1 IRS-2 double
deficient (IRS-1
/
IRS-2
/
).
We show here that IRS-1 IRS-2 double-deficient cells have no ability to
differentiate into adipocytes. We also show that the simultaneous lack
of both IRS-1 and IRS-2 dramatically decreases the expression of
C/EBP
and PPAR
at both the mRNA and the protein levels during
adipocyte differentiation. Thus, our data provide the first direct
evidence for the essential role of IRS-1 and IRS-2 in the expression of
adipose-specific transcriptional factors, such as the C/EBP family and
PPAR
, and adipocyte differentiation.
 |
MATERIALS AND METHODS |
Materials.
The probe for Northern blot and RNase protection
assay to 36B4 was a generous gift from Naoya Yahagi (University of
Tokyo) (34). The polyclonal antibodies to IRS-1,
phosphotyrosine, PPAR
, and C/EBP
were from Santa Cruz
Biotechnology, Inc. Polyclonal antibodies to phospho-mitogen-activated
protein kinase (MAPK) and MAPK were from New England Biolabs, Inc. The
medium and penicillin-streptomycin solution were purchased from Gibco,
Inc. Fetal bovine serum (FBS) was from JRH Biosciences. The
nitrocellulose paper used for the immunoblots was from Schleicher & Schuell, Inc. The 3-isobutyl-1-methylxanthine (IBMX) and human
recombinant insulin were purchased from Sigma Chemical Co.
Dexamethasone (DEX) was purchased from Wako Pure Chemical Industries,
Ltd. L-type Wako TG-H (S-R1 and S-R2) for triglyceride measurement was
purchased from Wako Pure Chemical Industries, Ltd. BCA Protein Assay
Reagent (Pierce) was used for the protein assay.
Preparation of wild-type, IRS-1
/
,
IRS-2
/
, and IRS-1
/
IRS-2
/
EFs.
The IRS-1 IRS-2 double-heterozygous
mice (IRS-1+/
IRS-2+/
mice) were generated
by intercrosses of IRS-1-deficient mice (38) and
IRS-2-deficient mice (22). To obtain embryos at 13.5 days past coitus, conceptuses that were obtained by fertilization in vitro
of ova from IRS-1+/
IRS-2+/
female mice
with sperm from IRS-1+/
IRS-2+/
male mice
were implanted into pseudopregnant foster mothers, as previously
described (21). The foster mothers were sacrificed at 13.5 days past coitus, the embryos were dissected from the uterus, and the
extra-embryonic membranes and viscera were removed. The embryos were
cut into small pieces with scissors and soaked for 30 min in 4 ml of
0.25% trypsin-EDTA at room temperature with shaking, and then
inactivated with
-modified Eagle medium (
MEM) supplemented with
10% heat-inactivated FBS, 50 U of penicillin per ml, and 50 µg of
streptomycin per ml. The cells were then suspended by pipetting and
were plated on two 10-cm dishes per embryo. After 48 h, adherent
cells were trypsinized, counted, and replated at a density of 1.2 × 105 cells/cm2 in
MEM with 10%
heat-inactivated FBS, 50 U of penicillin per ml, and 50 µg of
streptomycin per ml to induce adipocyte differentiation.
Induction of adipocyte differentiation.
The passage number
of the EF cells used in these studies was within two passages.
Induction of adipocyte differentiation was performed as previously
described (39). In brief, cells were cultured on 24- or
6-well or 10-cm plastic dishes and propagated to confluence. Two days
later, the medium was replaced with standard differentiation induction
medium containing 0.5 mM IBMX, 1 µM DEX, 5 µg of insulin per ml,
10% FBS, 50 U of penicillin per ml, and 50 µg of streptomycin per
ml, and the medium was renewed every other day.
Oil-Red O staining and triglyceride-protein assay.
Oil-Red O
staining solution (0.5% Oil-Red O in isopropyl alcohol
solution-distilled water [60:40]) was filtered through the Whatman
no. 1 filter paper and, after the cells were washed with phosphate-buffered saline (PBS), they were stained with the filtered staining solution for 30 min at 37°C and then washed with distilled water three times.
For the triglyceride-protein assay, the cells were washed with PBS
twice, 0.8 ml of homogenizing buffer (150 mM sodium chloride, 10 mM
Tris-HCl [pH 8.0], 0.1% Triton X-100) was added to each well of a
24-well plate, and the adherent cells were homogenized with Polytron.
The homogenate was filtered with Samprep (0.2 µm [pore size];
Millipore), and the concentration of triglyceride in the filtered
homogenate was measured by using L-type Wako TG-H (S-R1 and S-R2), and
a triolein diluted with the homogenizing buffer was used as the
standard. A 125-µl volume of the homogenate, 50 µl of S-R1, and 25 µl of S-R2 were used. The protein concentration of the same
homogenate solution was measured with a bicinchoninic acid (BCA) assay kit.
Retrovirus-mediated gene transfer.
To rescue adipocyte
differentiation of EF cells from IRS1
/
IRS2
/
, the PPAR
2 expression vector for
retrovirus-mediated gene transfer was constructed by ligating the
BstXI fragment from the pBabe-mPPAR
2-puro (kindly
provided by Bruce M. Spiegelman) into the BstXI site of pMX-puro (27). Mouse EF cells were infected with equal
titers of each recombinant virus as described previously
(44), with some modification.
PI 3-kinase assay.
PI 3-kinase activity in EF cells was
determined in immunoprecipitates with antibodies to phosphotyrosine as
described previously (55), with some modification. In
brief, EF cells were lysed with lysis buffer (0.25 M sucrose; 5 mM
EDTA; 5 mM EGTA; 20 mM Tris-HCl, pH 7.4; 0.2 mM
Na3VO4; 10 mM NaF; 10 mM sodium
PPi, 1 mM phenylmethylsulfonyl fluoride; 10 µg of
leupeptin per ml; 10 µg of aprotinin per ml) containing 1% NP-40.
The lysates were cleared by centrifugation at 12,000 rpm in a
microcentrifuge at 4°C, and the protein content of the supernatant
was determined. Then, 50 µg of the cellular protein was subjected to
immunoprecipitation with monoclonal antiphosphotyrosine antibody (PY20;
Santa Cruz) by using protein G-Sepharose, and the buffer was changed to
PI 3-kinase assay buffer (100 mM sodium chloride; 25 mM Tris-HCl, pH
7.4; 0.5 mM EGTA). The PI 3-kinase activity was then measured as
described previously (55).
RNA preparation, Northern blot analysis and RNase protection
assay.
Total RNA was prepared from EF cells with Trizol
(Gibco-BRL) according to the manufacturer's instructions.
Northern blot analysis was performed by a standard protocol. A 6-µg
sample of total RNA was electrophoresed through denaturing
formaldehyde-agarose (1%) gel and then transferred to a Hybond
N
+ nylon membrane (Amersham). cRNA probes for C/EBP

,
C/EBP

, C/EBP

,
PPAR

, LPL, and 36B4 were labeled by in vitro
transcription with
Strip-EZ RNA (Ambion) and [

-
32P]UTP
(NEN Life Science Products, Boston, Mass.). The cDNA probe
for aP2 was
labeled by random priming with the Megaprime DNA Labeling
System
(Amersham) and [

-
32P]dCTP (NEN Life Science Products).
A probe for SREBP1c that does
not detect SREBP1a was designed and
constructed as described previously
(
35).
The RNase protection assay to measure SREBP1c mRNA and PPAR

was
performed with RPA III (Ambion). A 10-µg sample of total
RNA was
hybridized with the cRNA probe, which was prepared with
MAXIscript
(Ambion) and [

-
32P]UTP (NEN Life Science
Products).
Immunoblot analysis.
EF cells were lysed in a lysis buffer
containing 1% NP-40, and insoluble materials were removed by
centrifugation. Proteins in the supernatants were assayed with a BCA
protein assay kit (Pierce) and then subjected to immunoblotting analysis.
The tyrosine-phosphorylated proteins associated with PI 3-kinase were
analyzed by immunoprecipitating equal amounts of protein
(100 µg)
with anti-PI 3-kinase p85 rabbit antiserum (anti-p85
PAN;
Upstate 06-195) and immunoblot analysis with the antiphosphotyrosine,
PY20-horseradish peroxidase (HRP) conjugate antibody, or 4G10-HRP
conjugate
antibody.
MAPK and phospho-MAPK were analyzed by electrophoresing 10 µg of
protein from the cell lysates via sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) on a 10% polyacrylamide gel and
immunoblotting with PhosphoPlus p44/p42 MAPK (Thr202-Tyr204) Antibody
Kit (New England Biolabs, Inc.) according to the manufacturer's
instructions.
PPAR

and C/EBP

were analyzed by electrophoresing 6 µg of
protein from the cell lysates by SDS-PAGE on a 12% polyacrylamide
gel,
followed by immunoblotting with PPAR

(H-100) rabbit polyclonal
immunoglobulin G (IgG) (1:500) and C/EBP

(14AA) rabbit polyclonal
IgG (1:500).
Histologic analysis.
To generate IRS-1
/
IRS-2
/
mice, conceptuses that were obtained by in vitro
fertilization of ova from IRS-1+/
IRS-2+/
female mice and sperm from IRS-1
/
IRS-2+/
male mice were implanted into pseudopregnant foster mothers, as
previously described (21). At 8 h after birth,
neonates were fixed in 10% formaldehyde in PBS. Genomic DNA was
prepared from the tail of each neonate, and the genotype was determined
by PCR analysis. Neonate was cut into 10-µm sections, and the
sections were mounted on silanized slides. The adipose tissue was
stained with hematoxylin and eosin. All sections were examined by light microscopy.
 |
RESULTS |
Adipocyte differentiation of IRS-1
/
cells is
impaired.
Wild-type and IRS-1
/
cells were induced
to differentiation into adipocytes. Oil-Red O staining was performed 8 days after induction of adipocyte differentiation (Fig.
1A), and the increase in intracellular triglyceride content was measured (Fig. 1B). The ability of
IRS-1
/
cells to differentiate into adipocytes was found
to be approximately 60% lower than that of wild-type cells. These
results were reproduced in six independent IRS-1
/
cells
with six independent wild-type cells as controls.

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 1.
Ability of wild-type and IRS-1 / cells to
differentiate into adipocytes. (A) Oil-Red O staining for fat
accumulation in wild-type and IRS-1 / cells at day 8 after induction. Cells were grown to confluence and then induced to
differentiation by exposure to IBMX, DEX, and insulin, as described in
Materials and Methods. (B) Increase in intracellular triglyceride
content from day 0 to day 8 after induction. The assays were performed
as described in Materials and Methods. The data represent the
means ± the standard errors of the means from four experiments.
Wild-type, n = 6; IRS-1 / , n = 6; **, P < 0.01.
|
|
PI 3-kinase activation during adipocyte differentiation in
IRS-1
/
cells was decreased.
PI 3-kinase activities
during adipocyte differentiation were measured in immunoprecipitates
with antibody to phosphotyrosine from lysates of wild-type cells and
IRS-1
/
cells (Fig. 2A).
PI 3-kinase activity increased during adipocyte differentiation and
reached a maximum at 8 days after induction, a result consistent with
observations in adipocyte cell lines 3T3-L1 and 3T3-F442A
(31). The increase in PI 3-kinase activity of in
IRS-1
/
cells during adipocyte differentiation was
approximately 50% less than that in the wild-type cells from 0 to 8 days after induction.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
Role of PI 3-kinase in adipocyte differentiation of
wild-type and IRS-1 / cells. (A) PI 3-kinase activities
during adipocyte differentiation. The antiphosphotyrosine antibody
(PY20) immunoprecipitates from 50 µg of protein of cellular lysates
of wild-type and IRS-1 / cells at the day indicated
after induction into adipocytes were subjected to a PI 3-kinase assay.
The autoradiograms of the spots corresponding to PIP are shown in the
upper panel. The radioactivity in the spots was measured, and the
results are shown in the lower panel, expressed as the ratios of the
values for the respective cells to those for wild-type cells at day 0 after induction. The data represent the means ± the standard
errors of the means from three independent experiments. **,
P < 0.01. (B) Effect of the PI 3-kinase inhibitor
LY294002 on adipocyte differentiation of wild-type and
IRS-1 / cells. LY294002 (20 µM) was added to adipocyte
differentiation medium, and the medium was changed at 36-h intervals.
As a control, 0.1% dimethyl sulfoxide was added to the medium, and the
medium was changed at the same intervals. At day 8 after induction, the
intracellular fat accumulation was assessed by staining with Oil-Red O. (C) Tyrosine-phosphorylated proteins associated with p85 subunit of PI
3-kinase. Total lysates (100 µg of protein each) of cells at day 8 after induction were immunoprecipitated with anti-p85PAN
(antibody to the p85 subunit of PI 3-kinase), and the
immunoprecipitates were subjected to SDS-PAGE followed by
immunoblotting with PY20 conjugated to HRP. (D) Association of IRS-1
with p85 subunit of PI 3-kinase. Total lysates (100 µg of protein
each) of cells at day 8 after induction were immunoprecipitated with
anti-p85PAN, and the immunoprecipitates were subjected to
SDS-PAGE, followed by immunoblotting with anti-IRS-1 antibody.
|
|
To address the importance of the increase in PI 3-kinase activity
during adipocyte differentiation, we investigated the effect
of a
synthetic PI 3-kinase inhibitor, LY294002, on the ability
of wild-type
and IRS-1
/
cells to differentiate into adipocytes.
LY294002 (20 µM) was
shown to completely block adipocyte
differentiation of both wild-type
and IRS-1
/
cells
(Fig.
2B), strongly suggesting that PI 3-kinase activity
was required
for adipocyte
differentiation.
We next studied the tyrosine-phosphorylated proteins associated with
the p85 subunit of PI 3-kinase during adipocyte differentiation
and
found that a 170-kDa protein in wild-type cells, but a 180-kDa
protein
in IRS-1
/
cells, was the major tyrosine phosphorylated
protein associated
with the p85 subunit of PI 3-kinase (Fig.
2C). The
170-kDa protein
was confirmed to be IRS-1 because this protein was
detected with
anti-IRS-1 antobody in wild-type cells and was not
detected in
IRS-1
/
cells (Fig.
2D). The 180-kDa protein
was strongly suggested to
be IRS-2, because this protein had a
molecular mass 10 kDa larger
than IRS-1 and was detected with
antiphosphotyrosine antibody
in IRS-1
/
cells, but not
in IRS-2
/
cells or IRS-1
/
IRS-2
/
cells (Fig.
3A).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 3.
PI 3-kinase and MAPK activities during adipocyte
differentiation in wild-type, IRS-1 / ,
IRS-2 / , and IRS-1 /
IRS-2 / cells. (A) Tyrosine-phosphorylated proteins
associated with p85 subunit of PI 3-kinase in cells with four different
genotypes, wild-type, IRS-1 / , IRS-2 / ,
and IRS-1 / IRS-2 / cells. Total lysates
(100 µg of protein each) of cells at day 0 and day 8 after induction
were immunoprecipitated with anti-p85PAN (antibody to the
p85 subunit of PI 3-kinase), and the immunoprecipitates were subjected
to SDS-PAGE, followed by immunoblotting with antiphosphotyrosine
antibody (4G10) conjugated to HRP. (B) PI 3-kinase activity associated
with tyrosine phosphorylated proteins in wild-type,
IRS-1 / , IRS-2 / , and
IRS-1 / IRS-2 / cells. The
immunoprecipitates with PY20 from cell lysates (50 µg of protein)
were subjected to the PI 3-kinase assay. The autoradiogram of the
thin-layer chromatograph is shown. (C) Levels of MAPK protein (upper
panel) and phosphorylation of MAPK (lower panel) during adipocyte
differentiation. Total lysates (10 µg of protein each) of cells with
the four different genotypes were subjected to immunoblotting as
described in Materials and Methods using antibody specific to either
MAPK or phospho-MAPK.
|
|
Since this residual PI 3-kinase activity associated with IRS-2 appeared
to partially rescue the ability of IRS1
/
cells to
differentiate into adipocytes, we then investigated
the ability of
IRS-2
/
cells and IRS-1
/
IRS-2
/
cells to differentiate into
adipocytes.
PI 3-kinase and MAPK activities during adipocyte differentiation in
wild-type, IRS-1
/
, IRS-2
/
, and
IRS-1
/
IRS-2
/
cells.
We performed
immunoblotting analysis to identify the tyrosine-phosphorylated
proteins associated with the p85 subunit of PI 3-kinase during
adipocyte differentiation (Fig. 3A). At day 0 after induction,
tyrosine-phosphorylated 170-kDa proteins, which were recognized by
anti-IRS-1 antibody (data not shown), were weakly detected in wild-type
and IRS-2
/
cells (Fig. 3A; lanes 1 and 3). At 8 days
after induction, tyrosine phosphorylation of IRS-1 associated with PI
3-kinase in wild-type and IRS-2
/
cells was markedly
increased (Fig. 3A, lanes 5 and 7). In IRS-1
/
cells,
tyrosine phosphorylation of the 180-kDa protein associated with the p85
subunit of PI 3-kinase was induced (Fig. 3A, lane 6). This protein was
shown to be IRS-2 because it was not detected in IRS-2
/
cells and IRS-1
/
IRS-2
/
cells (Fig. 3A,
lanes 7 and 8). In IRS-1
/
IRS-2
/
cells,
tyrosine-phosphorylated proteins associated with the p85 subunit of PI
3-kinase were not detected in the 170- to 180-kDa range (Fig. 3A, lane 8).
The PI 3-kinase activities which were immunoprecipitated with PY20
during adipocyte differentiation were measured in lysates
from each of
the four genotypes (Fig.
3B). IRS-1
/
cells had 50%
less PI 3-kinase activity than the wild-type cells,
whereas the PI
3-kinase activity of IRS-2
/
cells was similar to
that of wild-type cells. As we predicted,
the increase in PI
3-kinase activity during adipocyte differentiation
was largely
abolished in IRS-1
/
IRS-2
/
cells. These
findings indicated that a major portion of PI 3-kinase
activity which
increased during adipocyte differentiation was
associated with IRS-1
and IRS-2.
A second important pathway activated through IRS-1 and IRS-2 is the
MAPK cascade. The amount and phosphorylation of MAPK protein
was very
similar among the cells of each of the four genotypes
and remained
constant during adipocyte differentiation (Fig.
3C).
IRS-1
/
IRS-2
/
cells failed to
differentiate into adipocytes.
The EF cells with each of the four
genotypes were induced to differentiation into adipocytes. Oil-Red O
staining was performed 8 days after induction to adipocyte
differentiation (Fig. 4A). The ability of
IRS-1
/
cells to differentiate into adipocytes was again
approximately 60% lower than that of wild-type cells. The ability of
IRS-2
/
cells to differentiate into adipocytes was
approximately 15% lower than that of wild-type cells (Fig. 4B).
Surprisingly, IRS-1
/
IRS-2
/
cells were
completely unable to differentiate into adipocytes (Fig. 4).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 4.
Adipocyte differentiation of EF cells with the four
different genotypes, i.e., wild-type, IRS-1 / ,
IRS-2 / , and IRS-1 /
IRS-2 / cells. (A) Oil-Red O staining for fat
accumulation in cells with the four different genotypes. Wild-type,
IRS-1 / , IRS-2 / , and
IRS-1 / IRS-2 / cells were grown to
confluence, exposed to IBMX, DEX, and insulin to induce differentiation
as described in Materials and Methods and then stained with Oil-Red O
at day 8 day after induction. (B) Intracellular triglyceride content
during adipocyte differentiation of wild-type, IRS-1 / ,
IRS-2 / , and IRS-1 /
IRS-2 / cells. The data represent the means ± the
standard errors of the means from the analysis of wild type
(n = 3), IRS-1 / (n = 4), IRS-2 / (n = 4), and
IRS-1 / IRS-2 / (n = 3)
cells. *, P < 0.05.
|
|
Expression of transcriptional factors for adipocyte differentiation
and adipogenic markers.
To identify the molecular mechanism for
the defective adipocyte differentiation in IRS-1
/
IRS-2
/
cells, we performed Northern blot analysis to
investigate gene expression of transcriptional factors for adipocyte
differentiation and adipogenic markers (Fig.
5A). The levels of C/EBP
expression in
IRS-1
/
and IRS-1
/
IRS-2
/
cells were comparable to those of wild-type
cells. Somewhat surprisingly, C/EBP
expression in
IRS-1
/
and IRS-1
/
IRS-2
/
cells was greater than that in wild-type cells.
By contrast, the expression of C/EBP
in IRS-1
/
IRS-2
/
cells was markedly reduced. The expression of
PPAR
was also severely decreased in IRS-1
/
IRS-2
/
cells. Although the expression of SREBP1c (ADD1)
was significantly reduced 4 and 8 days after induction in
IRS-1
/
IRS-2
/
cells, it caught up with
that of wild-type cells by 12 days after induction. The expression of
LPL and aP2 mRNAs was severely decreased but not abolished in
IRS-1
/
IRS-2
/
cells.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 5.
(A) Northern blotting analysis and RNase protection
assay of transcriptional factors for adipocyte differentiation and
adipogenic markers in wild-type, IRS-1 / ,
IRS-2 / , and IRS-1 /
IRS-2 / cells during adipocyte differentiation. Total
RNAs were extracted from adipocytes at days 0, 2, 4, 8, and 12 after
induction, and a 6-µg sample of the total RNA was subjected to
electrophoresis and hybridization with probes consisting of
32P-labeled cRNAs encoding C/EBP , C/EBP , C/EBP ,
and 36B4 (upper panel) and with probes consisting of
32P-labeled cDNAs encoding aP2 and LPL. In an RNase
protection assay, 10 µg of the total RNA was hybridized with cRNA
encoding PPAR , SREBP1c, and 36B4 (lower panel). 36B4 encodes acidic
ribosomal phosphoprotein P0 and was used as a loading control. (B)
Effect of the PI 3-kinase inhibitor LY294002 on expression of the mRNAs
of PPAR and C/EBP in wild-type cells. LY294002 (20 µM) was
added to adipocyte differentiation medium, and the medium was changed
at 36-h intervals. As a control, 0.1% dimethyl sulfoxide was added to
the medium, and the medium was changed at the same intervals. At day 8 after induction, total RNAs were extracted from wild-type cells, and a
6-µg sample of total RNA was electrophoresed and subjected to
Northern blotting with PPAR and C/EBP .
|
|
To further study the role of PI 3-kinase in adipocyte differentiation
in EF cells, the mRNAs of PPAR

and C/EBP

in wild-type
cells were
examined by Northern blotting. Expressions of both
PPAR

and C/EBP

at 8 days after induction were severely decreased
in wild-type cells
treated with 20 µM LY294002 (Fig.
5B).
Expression of PPAR
and C/EBP
was markedly reduced on the
protein level in IRS-1
/
IRS-2
/
cells.
Immunoblotting analysis was performed to assess the
expression of PPAR
and C/EBP
on the protein level. The expression
of C/EBP
was markedly reduced on the protein level in
IRS-1
/
IRS-2
/
cells at 8 days after
induction (Fig. 6A), and the PPAR
protein level in IRS-1
/
IRS-2
/
cells
was also markedly reduced (Fig. 6B). These results were consistent with
those obtained by Northern blotting analysis of the
IRS-1
/
IRS-2
/
cells.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 6.
Immunoblot analysis of C/EBP (A) and PPAR (B) in
wild-type, IRS-1 / , IRS-2 / , and
IRS-1 / IRS-2 / cells during adipocyte
differentiation. Cells were grown to confluence and then exposed to
IBMX, DEX, and insulin to induce differentiation. At days 0 and 8 after
induction, the cells were lysed, and the lysates (6 µg of protein
each) were subjected to SDS-PAGE, followed by immunoblotting with
anti-C/EBP antibody (A) and anti-PPAR antibody (B) as described
in Materials and Methods. In an immunoblot analysis of PPAR (B),
PPAR -deficient cells described in a previous report
(21) and the CV-1 cells in which PPAR 1 or PPAR 2 was
overexpressed were also used as control samples.
|
|
Retroviral expression of PPAR
2 in IRS-1
/
IRS-2
/
cells partially rescued the lack of adipocyte
differentiation.
If the lack of PPAR
expression was responsible
for the observed lack of lipid accumulation in IRS-1
/
IRS-2
/
cells, it was thought that forced expression of
PPAR
might rescue adipocyte differentiation. To determine whether it
would, we performed retrovirus-mediated PPAR
gene transfer into
IRS-1
/
IRS-2
/
cells. The results of
Oil-Red O staining showed that forced expression of PPAR
2 in
IRS-1
/
cells completely rescued the impaired adipocyte
differentiation. Forced expression of PPAR
2 in
IRS-1
/
IRS-2
/
cells, however, rescued
it only in part, not to the same level as in mock-vector-transferred
wild-type cells (Fig. 7), suggesting that
IRS-1 and IRS-2 are required for full adipocyte differentiation in
addition to their roles to induce PPAR
2.

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 7.
Retrovirus-mediated reexpression of PPAR improved the
differentiation capacity of IRS-1 /
IRS-2 / cells. Wild-type, IRS-1 / , or
IRS-1 / IRS-2 / cells were transfected
with pMX-mPPAR 2-puro and mock vector by retrovirus-mediated gene
transfer as described in Materials and Methods. At day 8 of
differentiation, cells were stained with Oil-Red O to assess the
intracellular fat accumulations.
|
|
WAT mass of IRS-1
/
IRS-2
/
double-knockout mice was markedly reduced.
To address whether the
in vitro effects observed in this study are translated into effects on
adiposity in vivo, we tried to produce IRS-1
/
IRS-2
/
double-knockout mice. Interestingly, they were
carried to term (R. Suzuki et al., unpublished data). Because white
adipose tissue (WAT) appears at birth during mouse development, mice at
the 8-h postnatal point were examined histologically (Fig.
8). At 8 h after birth, control
animals had abundant subcutaneous WAT. In contrast, WAT mass was
dramatically reduced, but not abrogated, in the newborn
IRS-1
/
IRS-2
/
double-knockout mice.
Surprisingly, brown adipose tissue (BAT) mass in IRS-1
/
IRS-2
/
double-knockout mice was almost the same as that
in control mice.

View larger version (135K):
[in this window]
[in a new window]
|
FIG. 8.
Histological analyses of IRS-1 /
IRS-2 / double-knockout mice showed severe reduction in
WAT but not in BAT. Transverse sections at the level of the neck were
made from ~8-h control (left) and IRS-1 /
IRS-2 / (right) mice. The sections were subjected to
hematoxylin and eosin staining. Magnifications: ×30 (top) and ×150
(bottom).
|
|
 |
DISCUSSION |
Adipocyte differentiation is an important aspect of energy
balance. Although cascades and networks of transcriptional factors during adipocyte differentiation have been investigated rather thoroughly, the signaling mechanism by extracellular hormones and
growth factors regulating the cascades and networks of adipose-specific transcriptional factors remains unclear (30). Insulin and
IGF-1 have been reported to play important roles in adipocyte
differentiation (5, 13, 14). In this study, we
investigated the role of IRS-1 and IRS-2, the two major common
substrates for insulin and IGF-1 receptor tyrosine kinases, in
adipocyte differentiation. Using a gene ablation strategy, we found
that the abilities of IRS-1
/
cells and
IRS-2
/
cells to differentiate into adipocytes were
reduced by 60 and 15%, respectively, compared to that of wild-type
cells. These results indicate that even though both IRS-1 and IRS-2 are
required for full capacity of adipocyte differentiation, IRS-1 plays a more role in adipocyte differentiation. Moreover, it is possible that
IRS-2 and IRS-1 may have rescued the phenotype of
IRS-1
/
and IRS-2
/
cells, respectively,
in adipocyte differentiation. Therefore, to fully understand the role
of IRS-1 and IRS-2 in adipocyte differentiation, we established IRS-1
IRS-2 double-deficient EF cells. Our results clearly show that
IRS-1
/
IRS-2
/
cells have no ability to
differentiate into adipocytes; providing the first direct evidence that
IRS-1 and IRS-2 are absolutely essential to adipocyte differentiation.
Since IRS-1 and IRS-2 are important mediators of insulin and IGF-1
actions, these data may imply that the absence of IRS-1 and IRS-2
impairs hormonal activation of adipogenesis. It should be noted,
however, that this study does not address which tyrosine kinase(s)
phosphorylate IRS-1 and IRS-2 during adipocyte differentiation. Therefore, it is possible that tyrosine phosphorylation of IRS-1 and
IRS-2 by putative upstream tyrosine kinase(s) other than insulin and
IGF-1 receptor tyrosine kinases plays a crucial role in in vitro
adipocyte differentiation or in vivo adipogenesis. Data from Chaika et
al. (6) suggest that the insulin receptor tyrosine kinase
was still capable of stimulating adipocyte differentiation even when
mutated such that it could no longer phosphorylate IRS proteins.
The present study strongly suggests the important role of
tyrosine-phosphorylated IRS-1 and IRS-2 and PI 3-kinase activation by
three lines of experimental results: (i) adipocyte differentiation capacity parallels PI 3-kinase activity, which increases during adipocyte differentiation, among the four genotypes; (ii) PI 3-kinase inhibitor completely blocks adipocyte differentiation; and (iii) phosphorylation of MAP kinase is unaltered in any of the four genotypes. Consistent with our results, several studies (31, 40,
47, 54) have reported that PI 3-kinase activity plays a role in
adipocyte differentiation by using dominant-negative p85, wortmannin,
or LY294002, inhibitors of PI 3-kinase. Moreover, Kohn et al. and Magun
et al. have demonstrated the role of activation of PI 3-kinase and one
of its downstream mediators, Akt, to induce adipocyte differentiation
by constitutive active form of Akt Ser/Thr kinase (20,
24). Taken together with these reports, the present study
strongly suggests that PI 3-kinase activity activated through induction
of tyrosine phosphorylation of IRS-1 and IRS-2 is essential to
adipocyte differentiation.
To further clarify the mechanism by which IRS-1 and IRS-2 fulfill their
role in adipocyte differentiation, we investigated the expression of
transcriptional factors for adipocyte differentiation and adipogenic
markers. The results show that the mRNA expression of C/EBP
and
PPAR
is severely decreased in IRS-1
/
IRS-2
/
cells, although the expression of C/EBP
is
unaltered and the expression of C/EBP
is even slightly increased. It
therefore seems possible that IRS-1 and IRS-2 upregulate the expression of C/EBP
and PPAR
, but the molecular link between IRS-1, IRS-2, and PI 3-kinase and the upregulation of these transcription factors is
unclear and requires further investigation. The expression of LPL and
aP2, whose promoters have a PPAR response element (PPRE), is parallel
to the expression of PPAR
. Although the expression of SREBP1c is at
least in part dependent on the expression of PPAR
, as previously
reported (21), SREBP1c has been reported to be also
regulated by many other factors (11). At day 12 after induction the expression of SREBP1c in IRS-1
/
IRS-2
/
cells is induced to almost the same amount as
that in wild-type cells. It indicates that upstream signaling
pathway(s) other than IRS-1 and IRS-2 may be involved in the
regulation of the expression of SREBP1c. Nevertheless, normal
expression of SREBP1c at day 12 is not sufficient to induce adipocyte
differentiation in IRS-1
/
IRS-2
/
cells.
To further study the role of PI 3-kinase in adipocyte differentiation,
we examined whether inhibition of PI 3-kinase during adipocyte
differentiation affects the mRNA expressions of PPAR
and C/EBP
in
wild-type cells. As shown in Fig. 5B, mRNAs of both PPAR
and
C/EBP
decrease significantly in wild-type cells treated with 20 µM
LY294002. It strongly suggests that the inhibition of PI 3-kinase
blocks adipogenesis due to severe reduction in expression of both
PPAR
and C/EBP
mRNAs. Our present data appear to differ from
those of a previous report (31) that the inhibition of PI
3-kinase in 3T3-F442A cells by expressing dominant-negative p85 does
not affect the expression of the transcription factor PPAR
at the
mRNA level using insulin and 5,8,11,14-eicosatetraynoic acid (ETYA) as
inducers for adipocyte differentiation (31). The reasons
for the apparent discrepancy between our data and those of Sakaue et
al. (31) are unknown at present but could be related to
differences in methods such as cell type (primary EF cells versus
3T3-F442A) or inducers for differentiation (IBMX, DEX, and insulin
versus ETYA and insulin) or means to inhibit PI 3-kinase (LY294002
versus dominant-negative p85). On the other hand, our present result
that PI 3-kinase inhibition using LY294002 decreases PPAR
mRNA is
consistent with the study by Xia and Serrero (54), in
which they demonstrated treatment of 3T3-L1 adipocytes with LY294002
inhibited PPAR
expression and adipocyte differentiation induced by
IBMX, DEX, and insulin. Identification of signals downstream of IRS-1
and IRS-2 mediating the upregulation of PPAR
and C/EBP
mRNA
expression is an important subject of future research.
Restoration of PPAR
to IRS-1
/
IRS-2
/
cells by retrovirus-mediated gene transfer partially rescues the
defective adipocyte differentiation. This is consistent with the
hypothesis that one of the roles of IRS-1 and IRS-2 in adipocyte
differentiation is upregulation of mRNA expression of PPAR
. On the
other hand, the fact that PPAR
is unable to completely rescue the
defective adipocyte differentiation suggests that IRS-1 and IRS-2 may
stimulate adipocyte differentiation via distinct mechanism(s) in
addition to induction of PPAR
.
Histological analyses of IRS-1
/
IRS-2
/
double-knockout mice show severe reduction in WAT but not in BAT. These
data may provide the evidence that the essential role of IRS-1 and
IRS-2 in adipocyte differentiation in vitro can be extended to that in
development of WAT in vivo. It should be noted, however, that WAT mass
is not completely abrogated in IRS-1
/
IRS-2
/
double-knockout mice. These differences in
adipogenesis between in vitro and in vivo have been previously observed
in the report of Tanaka et al. on C/EBP
and C/EBP
knockout mice
(39). In in vitro differentiation experiments, the only
differentiation stimuli are MIX, DEX, INS and FBS; however, in vivo,
there are many other adipogenic factors such as growth hormone, IGF-1,
and prostaglandins. With the restricted number of stimuli in vitro, IRS-1 and IRS-2 is absolutely required for the expression of PPAR
and C/EBP
and for adipocyte differentiation. However, the lack of
adipogenesis may be partially rescued with additional stimuli in vivo
which are not absolutely dependent upon the presence of IRS-1 and
IRS-2.
In conclusion, this study is the first to report that IRS-1 and IRS-2
play an essential role in adipocyte differentiation and adipogenesis.
Moreover, we propose that IRS-1 and IRS-2 play crucial roles in
adipocyte differentiation through the upregulation of mRNA expression
of PPAR
and C/EBP
subsequent to induction of C/EBP
and
C/EBP
(Fig. 9).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 9.
Schematic model of the roles of IRS-1 and IRS-2 in
adipogenesis. IRS-1 and IRS-2 play a crucial role in the upregulation
of the expression of C/EBP and PPAR and adipocyte
differentiation.
|
|
 |
ACKNOWLEDGMENTS |
We thank B. M. Spiegelman and N. Yahagi for providing PPAR
2
expression vector and 36B4 cDNA probe, respectively, and E. Yoshida-Nagata and H. Chiyonobu for excellent technical assistance.
This work was supported by a grant-in-aid for creative basic research
(10NP0201) from the Ministry of Education, Science, Sports, and Culture
of Japan (to T. Kadowaki) and by health science research grants
(Research on Human Genome and Gene Therapy) from the Ministry of Health
and Welfare (to T. Kadowaki).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Internal Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 81-3-5800-8818. Fax: 81-3-5689-7209. E-mail:
kadowaki-3im{at}h.u-tokyo.ac.jp.
 |
REFERENCES |
| 1.
|
Akira, S.,
H. Isshiki,
T. Sugita,
O. Tanabe,
S. Kinoshita,
Y. Nishio,
T. Nakajima,
T. Hirano, and T. Kishimoto.
1990.
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
EMBO J.
9:1897-1906[Medline].
|
| 2.
|
Altiok, S.,
M. Xu, and B. M. Spiegelman.
1997.
PPAR induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.
Genes Dev.
11:1987-1998[Abstract/Free Full Text].
|
| 3.
|
Bruning, J. C.,
J. Winnay,
B. Cheatham, and C. R. Kahn.
1997.
Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
Mol. Cell. Biol.
17:1513-1521[Abstract].
|
| 4.
|
Cao, Z.,
R. M. Umek, and S. L. McKnight.
1991.
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Genes Dev.
5:1538-1552[Abstract/Free Full Text].
|
| 5.
|
Catalioto, R. M.,
D. Gailard,
G. Ailhaud, and R. Negrel.
1992.
Terminal differentiation of mouse preadipocyte cells: the mitogenic-adipogenic role of growth hormone is mediated by the protein kinase C signalling pathway.
Growth Factors
6:255-264[Medline].
|
| 6.
|
Chaika, O. V.,
N. Chaika,
D. J. Volle,
P. A. Wilden,
S. J. Pirrucello, and R. E. Lewis.
1997.
CSF-1 receptor/insulin receptor chimera permits CSF-1-dependent differentiation of 3T3-L1 preadipocytes.
J. Biol. Chem.
272:11968-11974[Abstract/Free Full Text].
|
| 7.
|
Chang, C. J.,
T. T. Chen,
H. Y. Lei,
D. S. Chen, and S. C. Lee.
1990.
Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family.
Mol. Cell. Biol.
10:6642-6653[Abstract/Free Full Text].
|
| 8.
|
Christy, R. J.,
K. H. Kaestner,
D. E. Geiman, and M. D. Lane.
1991.
CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes.
Proc. Natl. Acad. Sci. USA
88:2593-2597[Abstract/Free Full Text].
|
| 9.
|
Christy, R. J.,
V. W. Yang,
J. M. Ntambi,
D. E. Geiman,
W. H. Landschulz,
A. D. Friedman,
Y. Nakabeppu,
T. J. Kelly, and M. D. Lane.
1989.
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.
Genes Dev.
3:1323-1335[Abstract/Free Full Text].
|
| 10.
|
Descombes, P.,
M. Chojkier,
S. Lichtsteiner,
E. Falvey, and U. Schibler.
1990.
LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein.
Genes Dev.
4:1541-1551[Abstract/Free Full Text].
|
| 11.
|
Foretz, M.,
C. Pacot,
I. Dugail,
P. Lemarchand,
C. Guichard,
X. Le Liepvre,
C. Berthelier-Lubrano,
B. Spiegelman,
J. B. Kim,
P. Ferre, and F. Foufelle.
1999.
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.
Mol. Cell. Biol.
19:3760-3768[Abstract/Free Full Text].
|
| 12.
|
Freytag, S. O.,
D. L. Paielli, and J. D. Gilbert.
1994.
Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells.
Genes Dev.
8:1654-1663[Abstract/Free Full Text].
|
| 13.
|
Green, H.,
M. Morikawa, and T. Nixon.
1985.
A dual effector theory of growth-hormone action.
Differentiation
29:195-198[CrossRef][Medline].
|
| 14.
|
Guller, S.,
R. E. Corin,
K. Yuan-Wu, and M. Sonenberg.
1991.
Up-regulation of vinculin expression in 3T3 preadipose cells by growth hormone.
Endocrinology
129:527-533[Abstract/Free Full Text].
|
| 15.
|
Hu, E.,
P. Tontonoz, and B. M. Spiegelman.
1995.
Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha.
Proc. Natl. Acad. Sci. USA
92:9856-9860[Abstract/Free Full Text].
|
| 16.
|
Kageyama, R.,
Y. Sasai, and S. Nakanishi.
1991.
Molecular characterization of transcription factors that bind to the cAMP responsive region of the substance P precursor gene. cDNA cloning of a novel C/EBP-related factor.
J. Biol. Chem.
266:15525-15531[Abstract/Free Full Text].
|
| 17.
|
Kim, J. B., and B. M. Spiegelman.
1996.
ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.
Genes Dev.
10:1096-1107[Abstract/Free Full Text].
|
| 18.
|
Kim, J. B.,
H. M. Wright,
M. Wright, and B. M. Spiegelman.
1998.
ADD1/SREBP1 activates PPAR through the production of endogenous ligand.
Proc. Natl. Acad. Sci. USA
95:4333-4337[Abstract/Free Full Text].
|
| 19.
|
Kliewer, S. A.,
B. M. Forman,
B. Blumberg,
E. S. Ong,
U. Borgmeyer,
D. J. Mangelsdorf,
K. Umesono, and R. M. Evans.
1994.
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.
Proc. Natl. Acad. Sci. USA
91:7355-7359[Abstract/Free Full Text].
|
| 20.
|
Kohn, A. D.,
S. A. Summers,
M. J. Birnbaum, and R. A. Roth.
1996.
Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation.
J. Biol. Chem.
271:31372-31378[Abstract/Free Full Text].
|
| 21.
|
Kubota, N.,
Y. Terauchi,
H. Miki,
H. Tamemoto,
T. Yamauchi,
K. Komeda,
S. Satoh,
R. Nakano,
C. Ishii,
T. Sugiyama,
K. Eto,
Y. Tsubamoto,
A. Okuno,
K. Murakami,
H. Sekihara,
G. Hasegawa,
M. Naito,
Y. Toyoshima,
S. Tanaka,
K. Shiota,
T. Kitamura,
T. Fujita,
O. Ezaki,
S. Aizawa,
R. Nagai,
K. Tobe,
S. Kimura, and T. Kadowaki.
1999.
PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
Mol. Cell
4:597-609[CrossRef][Medline].
|
| 22.
|
Kubota, N.,
K. Tobe,
Y. Terauchi,
K. Eto,
T. Yamauchi,
R. Suzuki,
Y. Tsubamoto,
K. Komeda,
R. Nakano,
H. Miki,
S. Satoh,
H. Sekihara,
S. Sciacchitano,
M. Lesniak,
Y. Akanuma,
S. Aizawa,
R. Nagai,
S. Kimura,
S. Taylor, and T. Kadowaki.
2000.
Disruption of insulin receptor substrate-2 causes type 2 diabetes due to liver insulin resistance and lack of compensatory -cell hyperplasia.
Diabetes
49:1800-1889.
|
| 23.
|
Lin, F. T., and M. D. Lane.
1994.
CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program.
Proc. Natl. Acad. Sci. USA
91:8757-8761[Abstract/Free Full Text].
|
| 24.
|
Magun, R.,
B. M. Burgering,
P. J. Coffer,
D. Pardasani,
Y. Lin,
J. Chabot, and A. Sorisky.
1996.
Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation.
Endocrinology
137:3590-3593[Abstract].
|
| 25.
|
Mandrup, S., and M. D. Lane.
1997.
Regulating adipogenesis.
J. Biol. Chem.
272:5367-5370[Free Full Text].
|
| 26.
|
Myers, M. G., Jr.,
X. J. Sun,
B. Cheatham,
B. R. Jachna,
E. M. Glasheen,
J. M. Backer, and M. F. White.
1993.
IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
Endocrinology
132:1421-1430[Abstract/Free Full Text].
|
| 27.
|
Onishi, M.,
T. Nosaka,
K. Misawa,
A. L. Mui,
D. Gorman,
M. McMahon,
A. Miyajima, and T. Kitamura.
1998.
Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation.
Mol. Cell. Biol.
18:3871-3879[Abstract/Free Full Text].
|
| 28.
|
Ridderstrale, M.,
E. Degerman, and H. Tornqvist.
1995.
Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes.
J. Biol. Chem.
270:3471-3474[Abstract/Free Full Text].
|
| 29.
|
Rosen, E. D.,
P. Sarraf,
A. E. Troy,
G. Bradwin,
K. Moore,
D. S. Milstone,
B. M. Spiegelman, and R. M. Mortensen.
1999.
PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.
Mol. Cell
4:611-617[CrossRef][Medline].
|
| 30.
|
Rosen, E. D.,
C. J. Walkey,
P. Puigserver, and B. M. Spiegelman.
2000.
Transcriptional regulation of adipogenesis.
Genes Dev
14:1293-1307[Free Full Text].
|
| 31.
|
Sakaue, H.,
W. Ogawa,
M. Matsumoto,
S. Kuroda,
M. Takata,
T. Sugimoto,
B. M. Spiegelman, and M. Kasuga.
1998.
Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase.
J. Biol. Chem.
273:28945-28952[Abstract/Free Full Text].
|
| 32.
|
Samuelsson, L.,
K. Stromberg,
K. Vikman,
G. Bjursell, and S. Enerback.
1991.
The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development.
EMBO J.
10:3787-3793[Medline].
|
| 33.
|
Schoonjans, K.,
J. Peinado-Onsurbe,
A. M. Lefebvre,
R. A. Heyman,
M. Briggs,
S. Deeb,
B. Staels, and J. Auwerx.
1996.
PPAR and PPAR activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
EMBO J.
15:5336-5348[Medline].
|
| 34.
|
Shimano, H.,
N. Yahagi,
M. Amemiya-Kudo,
A. H. Hasty,
J. Osuga,
Y. Tamura,
F. Shionoiri,
Y. Iizuka,
K. Ohashi,
K. Harada,
T. Gotoda,
S. Ishibashi, and N. Yamada.
1999.
Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes.
J. Biol. Chem.
274:35832-35839[Abstract/Free Full Text].
|
| 35.
|
Shimomura, I.,
H. Shimano,
J. D. Horton,
J. L. Goldstein, and M. S. Brown.
1997.
Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.
J. Clin. Investig.
99:838-845[Medline].
|
| 36.
|
Spiegelman, B. M.,
E. Hu,
J. B. Kim, and R. Brun.
1997.
PPAR gamma and the control of adipogenesis.
Biochimie
79:111-112[Medline].
|
| 37.
|
Sun, X. J.,
L. M. Wang,
Y. Zhang,
L. Yenush,
M. G. Myers, Jr.,
E. Glasheen,
W. S. Lane,
J. H. Pierce, and M. F. White.
1995.
Role of IRS-2 in insulin and cytokine signalling.
Nature
377:173-177[CrossRef][Medline].
|
| 38.
|
Tamemoto, H.,
T. Kadowaki,
K. Tobe,
T. Yagi,
H. Sakura,
T. Hayakawa,
Y. Terauchi,
K. Ueki,
Y. Kaburagi,
S. Satoh,
H. Sekihara,
S. Yoshioka,
H. Horikoshi,
Y. Furuta,
Y. Ikawa,
M. Kasuga,
Y. Yazaki, and S. Aizawa.
1994.
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.
Nature
372:182-186[CrossRef][Medline].
|
| 39.
|
Tanaka, T.,
N. Yoshida,
T. Kishimoto, and S. Akira.
1997.
Defective adipocyte differentiation in mice lacking the C/EBP and/or C/EBP gene.
EMBO J.
16:7432-7443[CrossRef][Medline].
|
| 40.
|
Tomiyama, K.,
H. Nakata,
H. Sasa,
S. Arimura,
E. Nishio, and Y. Watanabe.
1995.
Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells.
Biochem. Biophys. Res. Commun.
212:263-269[CrossRef][Medline].
|
| 41.
|
Tontonoz, P.,
E. Hu,
J. Devine,
E. G. Beale, and B. M. Spiegelman.
1995.
PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene.
Mol. Cell. Biol.
15:351-357[Abstract].
|
| 42.
|
Tontonoz, P.,
E. Hu,
R. A. Graves,
A. I. Budavari, and B. M. Spiegelman.
1994.
mPPAR 2: tissue-specific regulator of an adipocyte enhancer.
Genes Dev.
8:1224-1234[Abstract/Free Full Text].
|
| 43.
|
Tontonoz, P.,
E. Hu, and B. M. Spiegelman.
1995.
Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma.
Curr. Opin. Genet. Dev.
5:571-576[CrossRef][Medline].
|
| 44.
|
Tontonoz, P.,
E. Hu, and B. M. Spiegelman.
1994.
Stimulation of adipogenesis in fibroblasts by PPAR 2, a lipid-activated transcription factor.
Cell
79:1147-1156[CrossRef][Medline].
|
| 45.
|
Tontonoz, P.,
J. B. Kim,
R. A. Graves, and B. M. Spiegelman.
1993.
ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation.
Mol. Cell. Biol.
13:4753-4759[Abstract/Free Full Text].
|
| 46.
|
Umek, R. M.,
A. D. Friedman, and S. L. McKnight.
1991.
CCAAT-enhancer binding protein: a component of a differentiation switch.
Science
251:288-292[Abstract/Free Full Text].
|
| 47.
|
Usui, I.,
T. Haruta,
M. Iwata,
A. Takano,
T. Uno,
J. Kawahara,
E. Ueno,
T. Sasaoka, and M. Kobayashi.
2000.
Retinoblastoma protein phosphorylation via PI 3-kinase and mTOR pathway regulates adipocyte differentiation.
Biochem. Biophys. Res. Commun.
275:115-120[CrossRef][Medline].
|
| 48.
|
Wang, N. D.,
M. J. Finegold,
A. Bradley,
C. N. Ou,
S. V. Abdelsayed,
M. D. Wilde,
L. R. Taylor,
D. R. Wilson, and G. J. Darlington.
1995.
Impaired energy homeostasis in C/EBP knockout mice.
Science
269:1108-1112[Abstract/Free Full Text].
|
| 49.
|
Williams, S. C.,
C. A. Cantwell, and P. F. Johnson.
1991.
A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro.
Genes Dev.
5:1553-1567[Abstract/Free Full Text].
|
| 50.
|
Wu, Z.,
N. L. Bucher, and S. R. Farmer.
1996.
Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBP , C/EBP , and glucocorticoids.
Mol. Cell. Biol.
16:4128-4136[Abstract].
|
| 51.
|
Wu, Z.,
E. D. Rosen,
R. Brun,
S. Hauser,
G. Adelmant,
A. E. Troy,
C. McKeon,
G. J. Darlington, and B. M. Spiegelman.
1999.
Cross-regulation of C/EBP and PPAR controls the transcriptional pathway of adipogenesis and insulin sensitivity.
Mol. Cell
3:151-158[CrossRef][Medline].
|
| 52.
|
Wu, Z.,
Y. Xie,
N. L. Bucher, and S. R. Farmer.
1995.
Conditional ectopic expression of C/EBP in NIH-3T3 cells induces PPAR and stimulates adipogenesis.
Genes Dev.
9:2350-2363[Abstract/Free Full Text].
|
| 53.
|
Wu, Z.,
Y. Xie,
R. F. Morrison,
N. L. Bucher, and S. R. Farmer.
1998.
PPAR induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBP during the conversion of 3T3 fibroblasts into adipocytes.
J. Clin. Investig.
101:22-32[Medline].
|
| 54.
|
Xia, X., and G. Serrero.
1999.
Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors.
J. Cell Physiol.
178:9-16[CrossRef][Medline].
|
| 55.
|
Yamauchi, T.,
K. Tobe,
H. Tamemoto,
K. Ueki,
Y. Kaburagi,
R. Yamamoto-Honda,
Y. Takahashi,
F. Yoshizawa,
S. Aizawa,
Y. Akanuma,
N. Sonenberg,
Y. Yazaki, and T. Kadowaki.
1996.
Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
Mol. Cell. Biol.
16:3074-3084[Abstract].
|
| 56.
|
Yeh, W. C.,
Z. Cao,
M. Classon, and S. L. McKnight.
1995.
Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins.
Genes Dev.
9:168-181[Abstract/Free Full Text].
|
Molecular and Cellular Biology, April 2001, p. 2521-2532, Vol. 21, No. 7
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.7.2521-2532.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Maeda, T., Horiuchi, N.
(2009). Simvastatin Suppresses Leptin Expression in 3T3-L1 Adipocytes via Activation of the Cyclic AMP-PKA Pathway Induced by Inhibition of Protein Prenylation. J Biochem
145: 771-781
[Abstract]
[Full Text]
-
Gagnon, A., Landry, A., Sorisky, A.
(2009). IKK{beta} and the anti-adipogenic effect of platelet-derived growth factor in human abdominal subcutaneous preadipocytes. J Endocrinol
201: 75-80
[Abstract]
[Full Text]
-
Bayol, S. A., Simbi, B. H., Bertrand, J. A., Stickland, N. C.
(2008). Offspring from mothers fed a 'junk food' diet in pregnancy and lactation exhibit exacerbated adiposity that is more pronounced in females. J. Physiol.
586: 3219-3230
[Abstract]
[Full Text]
-
Noguchi, M., Hosoda, K., Fujikura, J., Fujimoto, M., Iwakura, H., Tomita, T., Ishii, T., Arai, N., Hirata, M., Ebihara, K., Masuzaki, H., Itoh, H., Narumiya, S., Nakao, K.
(2007). Genetic and Pharmacological Inhibition of Rho-associated Kinase II Enhances Adipogenesis. J. Biol. Chem.
282: 29574-29583
[Abstract]
[Full Text]
-
Naiki, T., Saijou, E., Miyaoka, Y., Sekine, K., Miyajima, A.
(2007). TRB2, a Mouse Tribbles Ortholog, Suppresses Adipocyte Differentiation by Inhibiting AKT and C/EBPbeta. J. Biol. Chem.
282: 24075-24082
[Abstract]
[Full Text]
-
Hadsell, D. L, Olea, W., Lawrence, N., George, J., Torres, D., Kadowaki, T., Lee, A. V
(2007). Decreased lactation capacity and altered milk composition in insulin receptor substrate null mice is associated with decreased maternal body mass and reduced insulin-dependent phosphorylation of mammary Akt. J Endocrinol
194: 327-336
[Abstract]
[Full Text]
-
Li, F.-Q., Singh, A. M., Mofunanya, A., Love, D., Terada, N., Moon, R. T., Takemaru, K.-I.
(2007). Chibby Promotes Adipocyte Differentiation through Inhibition of {beta}-Catenin Signaling. Mol. Cell. Biol.
27: 4347-4354
[Abstract]
[Full Text]
-
Kim, J. J., Kido, Y., Scherer, P. E., White, M. F., Accili, D.
(2007). Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2. Am. J. Physiol. Endocrinol. Metab.
292: E1694-E1701
[Abstract]
[Full Text]
-
Zhao, J. J., Cheng, H., Jia, S., Wang, L., Gjoerup, O. V., Mikami, A., Roberts, T. M.
(2006). The p110{alpha} isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc. Natl. Acad. Sci. USA
103: 16296-16300
[Abstract]
[Full Text]
-
Bujalska, I J, Quinkler, M, Tomlinson, J W, Montague, C T, Smith, D M, Stewart, P M
(2006). Expression profiling of 11{beta}-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes.. J Mol Endocrinol
37: 327-340
[Abstract]
[Full Text]
-
Sadagurski, M., Yakar, S., Weingarten, G., Holzenberger, M., Rhodes, C. J., Breitkreutz, D., LeRoith, D., Wertheimer, E.
(2006). Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.. Mol. Cell. Biol.
26: 2675-2687
[Abstract]
[Full Text]
-
Baudry, A., Yang, Z.-Z., Hemmings, B. A.
(2006). PKB{alpha} is required for adipose differentiation of mouse embryonic fibroblasts. J. Cell Sci.
119: 889-897
[Abstract]
[Full Text]
-
Suzuki, R., Tobe, K., Aoyama, M., Sakamoto, K., Ohsugi, M., Kamei, N., Nemoto, S., Inoue, A., Ito, Y., Uchida, S., Hara, K., Yamauchi, T., Kubota, N., Terauchi, Y., Kadowaki, T.
(2005). Expression of DGAT2 in White Adipose Tissue Is Regulated by Central Leptin Action. J. Biol. Chem.
280: 3331-3337
[Abstract]
[Full Text]
-
Phan, J., Peterfy, M., Reue, K.
(2004). Lipin Expression Preceding Peroxisome Proliferator-activated Receptor-{gamma} Is Critical for Adipogenesis in Vivo and in Vitro. J. Biol. Chem.
279: 29558-29564
[Abstract]
[Full Text]
-
Scavo, L. M., Karas, M., Murray, M., Leroith, D.
(2004). Insulin-Like Growth Factor-I Stimulates Both Cell Growth and Lipogenesis during Differentiation of Human Mesenchymal Stem Cells into Adipocytes. J. Clin. Endocrinol. Metab.
89: 3543-3553
[Abstract]
[Full Text]
-
Yoo, H., Stephanopoulos, G., Kelleher, J. K.
(2004). Quantifying carbon sources for de novo lipogenesis in wild-type and IRS-1 knockout brown adipocytes. J. Lipid Res.
45: 1324-1332
[Abstract]
[Full Text]
-
Sasaoka, T., Wada, T., Fukui, K., Murakami, S., Ishihara, H., Suzuki, R., Tobe, K., Kadowaki, T., Kobayashi, M.
(2004). SH2-containing Inositol Phosphatase 2 Predominantly Regulates Akt2, and Not Akt1, Phosphorylation at the Plasma Membrane in Response to Insulin in 3T3-L1 Adipocytes. J. Biol. Chem.
279: 14835-14843
[Abstract]
[Full Text]
-
NANDI, A., KITAMURA, Y., KAHN, C. R., ACCILI, D.
(2004). Mouse Models of Insulin Resistance. Physiol. Rev.
84: 623-647
[Abstract]
[Full Text]
-
Tseng, Y.-H., Kriauciunas, K. M., Kokkotou, E., Kahn, C. R.
(2004). Differential Roles of Insulin Receptor Substrates in Brown Adipocyte Differentiation. Mol. Cell. Biol.
24: 1918-1929
[Abstract]
[Full Text]
-
Waki, H., Yamauchi, T., Kamon, J., Ito, Y., Uchida, S., Kita, S., Hara, K., Hada, Y., Vasseur, F., Froguel, P., Kimura, S., Nagai, R., Kadowaki, T.
(2003). Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes: MOLECULAR STRUCTURE AND MULTIMER FORMATION OF ADIPONECTIN. J. Biol. Chem.
278: 40352-40363
[Abstract]
[Full Text]
-
Sakaue, H., Nishizawa, A., Ogawa, W., Teshigawara, K., Mori, T., Takashima, Y., Noda, T., Kasuga, M.
(2003). Requirement for 3-Phosphoinositide-dependent Kinase-1 (PDK-1) in Insulin-induced Glucose Uptake in Immortalized Brown Adipocytes. J. Biol. Chem.
278: 38870-38874
[Abstract]
[Full Text]
-
Sekimoto, H., Boney, C. M.
(2003). C-Terminal Src Kinase (CSK) Modulates Insulin-Like Growth Factor-I Signaling through Src in 3T3-L1 Differentiation. Endocrinology
144: 2546-2552
[Abstract]
[Full Text]
-
Stefan, N., Kovacs, P., Stumvoll, M., Hanson, R. L., Lehn-Stefan, A., Permana, P. A., Baier, L. J., Tataranni, P. A., Silver, K., Bogardus, C.
(2003). Metabolic Effects of the Gly1057Asp Polymorphism in IRS-2 and Interactions With Obesity. Diabetes
52: 1544-1550
[Abstract]
[Full Text]
-
Peng, X.-d., Xu, P.-Z., Chen, M.-L., Hahn-Windgassen, A., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W. S., Crawford, S. E., Coleman, K. G., Hay, N.
(2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev.
17: 1352-1365
[Abstract]
[Full Text]
-
Valverde, A. M., Arribas, M., Mur, C., Navarro, P., Pons, S., Cassard-Doulcier, A.-M., Kahn, C. R., Benito, M.
(2003). Insulin-induced Up-regulated Uncoupling Protein-1 Expression Is Mediated by Insulin Receptor Substrate 1 through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Fetal Brown Adipocytes. J. Biol. Chem.
278: 10221-10231
[Abstract]
[Full Text]
-
Mur, C., Arribas, M., Benito, M., Valverde, A. M.
(2003). Essential Role of Insulin-Like Growth Factor I Receptor in Insulin-Induced Fetal Brown Adipocyte Differentiation. Endocrinology
144: 581-593
[Abstract]
[Full Text]
-
Ikonomov, O. C., Sbrissa, D., Mlak, K., Shisheva, A.
(2002). Requirement for PIKfyve Enzymatic Activity in Acute and Long-Term Insulin Cellular Effects. Endocrinology
143: 4742-4754
[Abstract]
[Full Text]
-
Valet, P., Tavernier, G., Castan-Laurell, I., Saulnier-Blache, J. S., Langin, D.
(2002). Understanding adipose tissue development from transgenic animal models. J. Lipid Res.
43: 835-860
[Abstract]
[Full Text]
-
Matsumoto, M., Ogawa, W., Teshigawara, K., Inoue, H., Miyake, K., Sakaue, H., Kasuga, M.
(2002). Role of the Insulin Receptor Substrate 1 and Phosphatidylinositol 3-Kinase Signaling Pathway in Insulin-Induced Expression of Sterol Regulatory Element Binding Protein 1c and Glucokinase Genes in Rat Hepatocytes. Diabetes
51: 1672-1680
[Abstract]
[Full Text]
-
Sakaue, H., Konishi, M., Ogawa, W., Asaki, T., Mori, T., Yamasaki, M., Takata, M., Ueno, H., Kato, S., Kasuga, M., Itoh, N.
(2002). Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev.
16: 908-912
[Abstract]
[Full Text]